Werewolf Therapeutics News

Werewolf Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(14.2%),Peter Kolchinsky(14.2%), etc.

May 7 16:59 ET

Werewolf Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(15.2%),Peter Kolchinsky(15.2%), etc.

Feb 14 17:23 ET

Werewolf Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-PFM Health Sciences, LP(9.6%),PFM Health Sciences GP, LLC(9.6%), etc.

Feb 14 16:14 ET

Werewolf Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BANK OF AMERICA CORPORATION(5.8%)

Feb 13 19:01 ET

Werewolf Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rubric Capital Management LP(5.35%),David Rosen(5.35%)

Feb 12 07:09 ET

Werewolf Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Atkins Michael B.

Jan 4 00:00 ET

Werewolf Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Atkins Michael B.

Jan 4 00:00 ET

Werewolf Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Trost Timothy W.

Jan 4 00:00 ET

Werewolf Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lubman Ellen

Jan 4 00:00 ET

Werewolf Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Isaacs Randi

Jan 4 00:00 ET

Werewolf Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer HICKLIN DANIEL J

Jan 4 00:00 ET

Werewolf Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Karunatilake Chulani

Jan 4 00:00 ET

Werewolf Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Seidel-Dugan Cynthia

Jan 4 00:00 ET

Werewolf Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Adage Capital Partners, L.P.(8.38%),Adage Capital Partners GP, L.L.C.(8.38%), etc.

Dec 21, 2023 16:30 ET

Werewolf Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.

Jun 23, 2023 17:09 ET

Werewolf Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Morrison Briggs

Jun 23, 2023 17:07 ET

Werewolf Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director EVNIN LUKE

Jun 23, 2023 16:53 ET

Werewolf Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lazarus Alon

Jun 23, 2023 16:52 ET

Werewolf Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director DiRocco Derek

Jun 23, 2023 16:52 ET

Werewolf Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Chatterjee Meeta

Jun 23, 2023 16:49 ET